These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22364820)

  • 1. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.
    Green DM; Collaco JM; McDougal KE; Naughton KM; Blackman SM; Cutting GR
    J Pediatr; 2012 Aug; 161(2):290-5.e1. PubMed ID: 22364820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heritability of lung disease severity in cystic fibrosis.
    Vanscoy LL; Blackman SM; Collaco JM; Bowers A; Lai T; Naughton K; Algire M; McWilliams R; Beck S; Hoover-Fong J; Hamosh A; Cutler D; Cutting GR
    Am J Respir Crit Care Med; 2007 May; 175(10):1036-43. PubMed ID: 17332481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modifiers of nutritional status in cystic fibrosis.
    Bradley GM; Blackman SM; Watson CP; Doshi VK; Cutting GR
    Am J Clin Nutr; 2012 Dec; 96(6):1299-308. PubMed ID: 23134884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
    Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
    Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
    Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1455X CFTR mutation and upper airway colonization with Pseudomonas aeruginosa.
    Kalampouka E; Petrocheilou A; Kaditis AG; Doudounakis SE
    Arch Bronconeumol; 2014 Nov; 50(11):499-500. PubMed ID: 24388274
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.
    Blackman SM; Hsu S; Vanscoy LL; Collaco JM; Ritter SE; Naughton K; Cutting GR
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1302-9. PubMed ID: 19126627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
    Green DM; McDougal KE; Blackman SM; Sosnay PR; Henderson LB; Naughton KM; Collaco JM; Cutting GR
    Respir Res; 2010 Oct; 11(1):140. PubMed ID: 20932301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics.
    Mekus F; Ballmann M; Bronsveld I; Bijman J; Veeze H; Tümmler B
    Twin Res; 2000 Dec; 3(4):277-93. PubMed ID: 11463149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
    Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins.
    Schamschula E; Hagmann W; Assenov Y; Hedtfeld S; Farag AK; Roesner LM; Wiehlmann L; Stanke F; Fischer S; Risch A; Tümmler B
    J Cyst Fibros; 2021 Jan; 20(1):149-153. PubMed ID: 32540173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.
    Blackman SM; Deering-Brose R; McWilliams R; Naughton K; Coleman B; Lai T; Algire M; Beck S; Hoover-Fong J; Hamosh A; Fallin MD; West K; Arking DE; Chakravarti A; Cutler DJ; Cutting GR
    Gastroenterology; 2006 Oct; 131(4):1030-9. PubMed ID: 17030173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Thompson V; Ramsey BW; Morgan W; Gibson RL;
    J Cyst Fibros; 2012 Sep; 11(5):446-53. PubMed ID: 22554417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.
    Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA
    Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection.
    Pier GB
    Curr Opin Microbiol; 2002 Feb; 5(1):81-6. PubMed ID: 11834374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and concordance of autism spectrum disorders among 277 twin pairs.
    Rosenberg RE; Law JK; Yenokyan G; McGready J; Kaufmann WE; Law PA
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):907-14. PubMed ID: 19805709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.
    Demko CA; Byard PJ; Davis PB
    J Clin Epidemiol; 1995 Aug; 48(8):1041-9. PubMed ID: 7775991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.